The partnership agreement includes research and development of AI features and air traffic management concepts Areas of ...
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...
Highlights: Cabaçal advances the next step towards Financial Investment Decision with the application for its Installation Licence; Cabaçal Feasibility Study is nearing 50% completion and remains on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results